 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 2 | 1/1 | 返回列表 |
| 查看: 569 | 回復: 1 | |||
| 本帖產生 1 個 翻譯EPI ，點擊這里進行查看 | |||
[求助]
求翻譯，謝謝，站內信
|
|||
|
Discussion The global antifungal market was estimated at $9.4 billion in 2010 and is expected to grow at a rate of 1.9% during 2010-2017. The major class of antifungal compound includes azoles, polyenes, pyrimidines, allyamines and echinodians. The antifungal therapies intend eradicating fungi through several action mechanisms, mainly involving destruction of cell wall and inhibition of cell division. There is a significant unmet need of novel anti- fungal compounds, because the present portfolio of treatments interact unfavorably with other medication, have resistance problem, low spectrum of activity, are fungistatic as opposed to fungicidal and are often toxic. Hence research has been focused on development of potent and safe antifungal compounds, either synthetic or from microbial sources [24]. In the present study, we exploited the marine resources for isolation of actinomycetes strains producing antifungal compounds. In the course of study, the marine invertebrate associated active acti- nomycetes strain PM0525875 was isolated and identified as Actinoalloteichus cyanogriseus. The antifungal principle from this strain was characterized as Caerulomycin A that showed potent in-vitro activity against pathogenic and drug resistant Candida strains. Caerulomycin A was first isolated from S. caeruleus [25] [26] as an antibiotic. Later it was reported to have anti-cancer activity [27]. In-vitro and in-vivo activity of Caerulomycin A against Entamoeba histolytica has been reported [28]. Natural derivatives of Caerulomycin A has also been reported [29]. Caerulomycin B and C, a new 2,2′-dipyridyl derivatives were isolated from Streptomyces caeruleus supplemented with 1 mM L-tryptophan. This group also reported the isolation of Caerulomycin D [19]. Additional natural derivatives of Caerulomycin F-K were isolated from marine derived actinomycetes (Actinoalloteichus cyanogriseus) that showed anticancer and antibacterial activity [29]. Lin et al. identified the biosynthetic gene cluster for Caerulomycin A from ma- rine actinomycetes Actinoalloteichus cyanogriseus. It mainly consists of unusual hybrid polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) [30]. The biosynthesis of Caerulomycin A based on enzy- matic modifications leading to structural changes, have been studied [31]. Chemical synthesis of Caerulomycin A-C has also been reported [32] [33]. The immunosuppressive activity of Caerulomycin A and its natural ana- logues has been reported [34]. Although Caerulomycin A has not been entered in clinic so far, may be due to its limitations, it could be the ideal molecule for generating semi synthetic druggable derivatives having potential application as an anticancer, antifungal or immunosuppressive drug. The strain and the optimized fermentation process described here could be useful for large scale production of this molecule for further drug development studies. 5. Conclusion In our in-house screening program in the quest of novel and superior antifungal compounds, an actinomycetes strain PM0525875 was isolated from a marine invertebrate. The active principle was characterized to be Caeru- lomycin A. Minimum inhibitory concentration (MIC) of the compound was found in the range of 0.39 - 1.56 μg/ml against pathogenic fungal test strains. The phylogenetic analysis of producer strain using 16S rRNA se- quence showed closest match with Actinoalloateichus cyanogriseus. Overall, Caerulomycin A was isolated from marine invertebrate-associated Actinoalloteichus sp. using optimized medium and fermentation conditions. |
回復此樓» 猜你喜歡
招08考數學
已經有11人回復
-
291求調劑
已經有4人回復
-
276求調劑
已經有4人回復
-
一志愿070300浙大化學358分，求調劑！
已經有4人回復
-
一志愿中南大學化學學碩0703總分337求調劑
已經有4人回復
-
一志愿北京化工大學 070300 學碩 336分 求調劑
已經有5人回復
-
323求調劑
已經有6人回復
-
352求調劑
已經有3人回復
-
一志愿東華大學化學070300，求調劑
已經有8人回復
-
277材料科學與工程080500求調劑
已經有7人回復
【答案】應助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
bxzc123: 金幣+30, 翻譯EPI+1, ★★★很有幫助, 翻譯一半？ 2014-10-18 18:44:26
bxzc123: 金幣+30, 翻譯EPI+1, ★★★很有幫助, 翻譯一半？ 2014-10-18 18:44:26
|
討論 2010年的評估指出抗菌劑的全球市場值為94億美元，而且從2010年至2017年間會以1.9%的速率不斷增長�？咕鷦┑闹饕煞趾蝾�、多烯類、嘧啶類、以及烯胺類 �？拐婢煼ㄔ噲D通過多種作用機制—主要是破壞細胞壁及抑制細胞的分解—來根除真菌。新型抗真菌化合物的需求量遠未得到滿足，其原因是現有的組合療法內部機制間存在相互抵制，且作用范圍小，其與抗菌劑的作用相悖，甚至會使抗菌劑失效。 因而有研究致力于開發(fā)高效、安全的抗真菌化合物，包括合成及從細菌中提取[24]。在本研究中，我們開發(fā)利用了細菌源進行放線菌株的隔離，來制取抗真菌化合物。我們在試驗中將海洋無脊椎動物的相關抗菌性菌株進行了隔離，并確定其為海洋來源放線菌。該菌株的抗菌性原理類似于淺藍霉素 A，其對致病性和耐藥性念珠菌菌株表現出很強的體外活性。 淺藍霉素 A是一種首次由S. caeruleus [25] [26]分離的抗生素。之后有報道稱其有抗癌作用[27]。淺藍霉素 A的體內抗痢疾變形蟲作用已經報道[28]。還有報道指出淺藍霉素 A的人工合成方法[29]。  |
2樓2014-10-17 20:42:24
相關版塊跳轉
我要訂閱樓主 bxzc123 的主題更新
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 291求調劑 +4 | 孅華 2026-03-22 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 328求調劑，英語六級551，有科研經歷 +6 | 生物工程調劑 2026-03-17 | 10/500 |
|
|
|
[考研] 求調劑院校信息 +6 | CX 330 2026-03-21 | 6/300 |
|
|
|
[考研] 303求調劑 +5 | 安憶靈 2026-03-22 | 6/300 |
|
|
|
[考研] 生物學一志愿985，分數349求調劑 +4 | zxts12 2026-03-21 | 7/350 |
|
|
|
[考研] 材料與化工（0856）304求B區(qū)調劑 +3 | 邱gl 2026-03-20 | 7/350 |
|
|
|
[考研] 材料學碩333求調劑 +3 | 北道巷 2026-03-18 | 3/150 |
|
|
|
[考研] 311求調劑 +3 | 勇敢的小吳 2026-03-20 | 3/150 |
|
|
|
[考研] 307求調劑 +3 | 余意卿 2026-03-18 | 3/150 |
|
|
|
[考研] 306求0703調劑一志愿華中師范 +5 | 紙魚ly 2026-03-21 | 5/250 |
|
|
|
[考研] 265求調劑 +12 | 梁梁校校 2026-03-19 | 14/700 |
|
|
|
[考研] 279分求調劑 一志愿211 +14 | chaojifeixia 2026-03-19 | 15/750 |
|
|
|
[考研] 材料學學碩080502 337求調劑-一志愿華中科技大學 +4 | 順順順mr 2026-03-18 | 5/250 |
|
|
|
[考研] 083200學碩321分一志愿暨南大學求調劑 +3 | innocenceF 2026-03-17 | 3/150 |
|
|
|
[考研] 332求調劑 +4 | ydfyh 2026-03-17 | 4/200 |
|
|
|
[考研] 一志愿中海洋材料工程專碩330分求調劑 +8 | 小材化本科 2026-03-18 | 8/400 |
|
|
|
[考研] 085600材料與化工 +8 | 安全上岸！ 2026-03-16 | 8/400 |
|
|
|
[考研] 一志愿西安交通大學 學碩 354求調劑211或者雙一流 +3 | 我想要讀研究生 2026-03-20 | 3/150 |
|
|
|
[考研] 081700化工學碩調劑 +3 | 【1】 2026-03-16 | 3/150 |
|
|
|
[考研] 材料，紡織，生物（0856、0710），化學招生啦 +3 | Eember. 2026-03-17 | 9/450 |
|